Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
Niagara Falls, NY, March 01, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a molecular...
Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
Plans for Clinical Study of New “Affinity PET-CT 4D” Nuclear Imaging Device
Positron Corporation Announces First Step in Validation of its New PET-CT Device
POSITRON CORPORATION ANNOUNCES KEY SALES & SERVICES PERSONNEL HIRE
POSITRON CORPORATION RETAINS FDA CONSULTING FIRM IN PREPARATION FOR 510K NEW DEVICE APPLICATION
POSITRON INVESTOR UPDATE
POSITRON ENTERS LONG TERM COOPERATION AGREEMENT WITH NEUSOFT MEDICAL SYSTEMS
POSITRON FILES FINANCIAL REPORTS & ANNOUNCES PINK CURRENT OTC REPORTING & DISCLOSURES STATUS